Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Clinical Evaluation of the GORE EXCLUDER® Bifurcated Endoprosthesis - Low Permeability in the Primary Treatment of Infrarenal Abdominal Aortic Aneurysms

NCT00593814 is registered in ClinicalTrials.gov with W.L.Gore & Associates as lead sponsor.

NCT NCT00593814
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00593814 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Clinical Evaluation of the GORE EXCLUDER® Bifurcated Endoprosthesis - Low Permeability in the Primary Treatment of Infrarenal Abdominal Aortic Aneurysms
Lead sponsor
W.L.Gore & Associates
Phase
Phase 4
Overall status
Completed
Start date
June 30, 2005
Completion date
February 28, 2009
Enrollment
139 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

aortic aneurysm, abdominal